Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT.

MLA

Stam, Barbara, et al. “Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT.” International Journal of Radiation Oncology, Biology, Physics, vol. 103, no. 1, Jan. 2019, pp. 132–41. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2018.08.040.

APA

Stam, B., Kwint, M., Guckenberger, M., Mantel, F., Hope, A., Giuliani, M., Werner-Wasik, M., Grills, I., Sonke, J.-J., & Belderbos, J. (2019). Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT. International Journal of Radiation Oncology, Biology, Physics, 103(1), 132–141. https://doi.org/10.1016/j.ijrobp.2018.08.040

Chicago

Stam, Barbara, Margriet Kwint, Matthias Guckenberger, Frederick Mantel, Andrew Hope, Meredith Giuliani, Maria Werner-Wasik, Inga Grills, Jan-Jakob Sonke, and José Belderbos. 2019. “Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT.” International Journal of Radiation Oncology, Biology, Physics 103 (1): 132–41. doi:10.1016/j.ijrobp.2018.08.040.